Cargando…
The Genomic Landscape of Juvenile Myelomonocytic Leukemia
Juvenile myelomonocytic leukemia (JMML) is a myeloproliferative neoplasm (MPN) of childhood with a poor prognosis. Mutations in NF1, NRAS, KRAS, PTPN11 and CBL occur in 85% of patients, yet there are currently no risk stratification algorithms capable of predicting which patients will be refractory...
Ejemplares similares
-
Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia
por: Stieglitz, Elliot, et al.
Publicado: (2017) -
Exploring the genetic and epigenetic origins of juvenile myelomonocytic leukemia using newborn screening samples
por: Behnert, Astrid, et al.
Publicado: (2021) -
Molecular and phenotypic diversity of CBLmutated juvenile myelomonocytic leukemia
por: Hecht, Anna, et al.
Publicado: (2020) -
Juvenile myelomonocytic leukemia in the molecular era: a clinician’s guide to diagnosis, risk stratification, and treatment
por: Wintering, Astrid, et al.
Publicado: (2021) -
Tretinoin Enhances the Effects of Chemotherapy in Juvenile Myelomonocytic Leukemia Using an Ex Vivo Drug Sensitivity Assay
por: Stieglitz, Elliot, et al.
Publicado: (2023)